Your Source for Venture Capital and Private Equity Financings

Vita Therapeutics Closes $31M Series B Financing.

2022-10-12
BALTIMORE, MD, Vita Therapeutics, a cell engineering company, announced the completion of a $31 million Series B financing.
Vita Therapeutics, a cell engineering company harnessing the power of genetics to develop novel cellular therapies to treat muscular dystrophies and cancers, today announced the completion of a $31 million Series B financing.

The fundraise was led by Cambrian BioPharma and new investor Solve FSHD. New investors included Riptide Ventures and Cedars Sinai, which participated alongside TEDCO and other existing investors.
(c) by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000+ startups and 5,000+ VC investors